Capecitabine and Oxaliplatin for Advanced Esophagogastric CancerDavid Cunningham, A. Norman, Naureen Starling et al.|New England Journal of Medicine|2008Cited by 2.3k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upGuillem Argilés, Dirk Arnold, Josep Tabernero et al.|Annals of Oncology|2020Cited by 1.3k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 studyRichard Fox, Daniel H. Palmer, Hassan Malik et al.|The Lancet Oncology|2019Cited by 1.2k
Duration of Adjuvant Chemotherapy for Stage III Colon CancerAxel Grothey, Timothy Iveson|New England Journal of Medicine|2018Cited by 1.1k
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trialYolanda Barbáchano, Ian Chau, David Cunningham et al.|The Lancet Oncology|2013Cited by 728